-
0.4% Trypan Blue Solution: Practical Guide
2026-08-31
0.4% Trypan Blue Solution supports rapid cell viability measurement by differentiating unstained viable cells from blue-stained dead or membrane-damaged cells during cell counting. It is suitable for research workflows and cytotoxicity assays, but it should not be used for diagnostic purposes or as a standalone method for mechanistic apoptosis and necrosis detection.
-
Primary Antibody Dilution Buffer for PCNSL
2026-08-30
Learn how Primary Antibody Dilution Buffer supports spatial validation of PCNSL metabolic discoveries. This article connects single-cell evidence on SLC2A5 with practical IHC, ICC, and antibody-dependent ISH assay design.
-
Novobiocin: From Mechanism to Translation
2026-08-29
A translational strategy for using Novobiocin as a mechanistically rich aminocoumarin antibiotic across antibacterial resistance research, parasitic disease, antiviral discovery, and apoptosis-focused workflows.
-
Complete Nicotine Biosynthesis: A Vacuolar Metabolon
2026-08-28
Chang et al. resolve the final steps of nicotine biosynthesis by identifying a glycosylation-dependent, stereoselective Mannich-like condensation and a vacuolar five-component metabolon that coordinates pathway chemistry with transport. The study combines omics, biochemical reconstitution, pathway perturbation, and heterologous plant engineering to establish a transferable framework for nicotine production and pest-resistance research.
-
Molnupiravir Protects Mice from Bourbon Virus Disease
2026-08-28
Bamunuarachchi and colleagues show that molnupiravir inhibits Bourbon virus replication in vitro and protects susceptible mice from lethal disease when given before or after infection. The study is notable for linking antiviral activity with reduced tissue viral burden, improved thrombocytopenia, restored splenic immune profiles, and less liver and spleen pathology.
-
Stattic: STAT3 Inhibitor for Cancer Research
2026-08-27
Stattic is a small-molecule STAT3 inhibitor that disrupts STAT3 dimerization and nuclear signaling. Product data support micromolar activity in HNSCC models, while independent evidence shows that Stattic can block cadmium-induced STAT3 responses in lymphatic endothelial cells.
-
Clarithromycin CYP3A Inhibitor Workflow
2026-08-27
Build reproducible CYP3A inhibition assays with Clarithromycin for statin metabolism interaction, cardiovascular disease drug interaction, and broader drug-drug interaction research. This workflow combines solvent-aware preparation, pathway-negative comparison, quantitative readouts, and troubleshooting for translational pharmacokinetic studies.
-
Triamcinolone Research Workflow Guide
2026-08-26
Triamcinolone (SKU B1859) provides a defined synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, storage, assay controls, and quality checks; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical applications.
-
NSP15 Screening Finds Thymopentin and Oleuropein
2026-08-26
This 2021 structure-based study screened a natural-product library against the SARS-CoV-2 endoribonuclease NSP15 and identified thymopentin and oleuropein as the highest-ranked candidates. Molecular-dynamics analysis supported stable protein–ligand complexes, but the findings remain computational and require biochemical, cellular, and infection-model validation.
-
Affordable GRO-seq for Bread Wheat Nascent RNA
2026-08-25
Chen et al. present a cost-efficient Global Run-On sequencing protocol for profiling nascent transcription in allohexaploid bread wheat. Its central innovation is rRNA depletion after nuclear RNA isolation and before nascent-RNA immunoprecipitation, which increased the proportion of valid sequencing data by 20-fold and enabled enhancer RNA analysis in a complex plant genome.
-
HyperFluor 488 Goat Anti-Mouse IgG in PRRSV Assays
2026-08-25
Learn how HyperFluor 488 Goat Anti-Mouse IgG can support orthogonal PRRSV detection workflows, from immunofluorescence to immunoblot confirmation. This evidence-led guide translates a 2024 PRRSV-1 isolation study into practical secondary-antibody and assay-design decisions.
-
Carbohydrate-Decorated Nanoparticles Target Macrophages
2026-08-24
The reference study developed biodegradable nanoparticles whose carbohydrate surface chemistry improved macrophage uptake and reporter-gene delivery. Mannose and dextran produced particularly useful targeting profiles, while the work also showed that carbohydrate identity and presentation influence both internalization and mRNA transfection.
-
Annexin V-Cy5 Apoptosis in Microglia
2026-08-24
The Annexin V-Cy5 Apoptosis Kit enables rapid Annexin V apoptosis detection while helping researchers distinguish phosphatidylserine exposure from lysosomal stress. This article develops an interpretation-first workflow for zebrafish microglia and other phagocytic systems.
-
5-Methyl-CTP: Practical IVT Workflow Guide
2026-08-23
5-Methyl-CTP helps researchers design modified mRNA workflows aimed at stronger transcript persistence and protein output. This guide connects reagent handling, controlled nucleotide substitution, analytical QC, and vaccine-oriented assay design without treating one formulation as universally optimal.
-
Lactylated NSUN2 Drives PDAC Perineural Invasion
2026-08-22
This 2026 Theranostics study identifies NSUN2 K692 lactylation as a metabolic mechanism linking lactate accumulation to RNA m5C-dependent stabilization of CDCP1 and STC1 in pancreatic ductal adenocarcinoma. Its combination of patient cohorts, neural invasion models, CRISPR mutants, RNA-binding analyses, and genetically engineered mice provides a mechanistic framework for understanding and potentially restraining perineural invasion.